Microbix Secures Third Ontario Manufacturing Site

By Pavel Zhelev | June 3, 2021

Microbix Announces Quality Products Distribution Agreement

By Pavel Zhelev | May 31, 2021 Microbix Announces Quality Products Distribution Agreement

Microbix Announces Closing of Offering and Private Placement

By Pavel Zhelev | May 19, 2021 Microbix Announces $6.0 Million of Financings

Microbix Reports Record Results for Q2 Fiscal 2021

By Pavel Zhelev | May 13, 2021 Record Q2 Sales of $4.35 million, Record Net Earnings of $0.8 million

Microbix Announces $6.0 Million of Financings

By Pavel Zhelev | April 28, 2021 Microbix Announces $6.0 Million of Financings

Microbix & SpeeDx Form Exclusive Collaboration

By Pavel Zhelev | April 26, 2021 Microbix & SpeeDx Form Exclusive Collaboration

Microbix Receives $4.25 Million Order For Viral Transport Medium

By Pavel Zhelev | April 23, 2021 Microbix Receives $4.25 Million Order For Viral Transport Medium

Microbix to Present at Bloom Burton Investor Conference

By Pavel Zhelev | April 19, 2021 Microbix to Present at Bloom Burton Investor Conference

Microbix Announces Annual and Special Meeting Voting Results

By Pavel Zhelev | March 31, 2021 Microbix Announces Annual and Special Meeting Voting Results

Microbix & Seegene Canada Form COVID-Variant Collaboration

By Pavel Zhelev | March 15, 2021 Microbix & Seegene Canada Form COVID-Variant Collaboration

Microbix Antigen-test QAPs Now Available For Clinical Use

By Pavel Zhelev | March 11, 2021 Microbix Antigen-test QAPs Now Available For Clinical Use

Microbix Announces Issuance of Stock Options

By Pavel Zhelev | February 18, 2021 Record Q2 Sales of $4.35 million, Record Net Earnings of $0.8 million

Microbix Announces Quality Products Distribution Agreement

By Pavel Zhelev | February 16, 2021 Microbix Announces Quality Products Distribution Agreement

Microbix Reports Results for Q1 Fiscal 2021

By Pavel Zhelev | February 11, 2021 Microbix Announces $6.0 Million of Financings

Microbix Announces Material First Sales of Viral Transport Medium

By Pavel Zhelev | February 9, 2021

Microbix Viral Transport Medium Now Available

By Pavel Zhelev | January 28, 2021 Microbix Receives $4.25 Million Order For Viral Transport Medium

Microbix & Copan Italia Execute Strategic Agreement

By Pavel Zhelev | December 21, 2020 Microbix Presenting COVID-19 Product Results To Industry

Microbix Reports Results for Fiscal 2020

By Pavel Zhelev | December 18, 2020 Microbix Announces $6.0 Million of Financings

Microbix Presenting Product Results at AACC

By Pavel Zhelev | December 15, 2020 Microbix & SpeeDx Form Exclusive Collaboration

Microbix Announces Addition to Board of Directors

By Pavel Zhelev | December 7, 2020 Microbix Announces Addition to Board of Directors

Microbix Discloses New Products, Sales, And Capacity

By Microbix Admin | October 29, 2020 Microbix Discloses New Products, Sales, And Capacity

Microbix Creates Further COVID-19 Quality Assessment Products

By Microbix Admin | October 20, 2020 Microbix Creates Further COVID-19 Quality Assessment Products

Ontario Helps Microbix Ensure Provincial COVID Testing Capacity

By Microbix Admin | October 13, 2020 Ontario Helps Microbix Ensure Provincial COVID Testing Capacity

Microbix Presenting COVID-19 Product Results To Industry

By Microbix Admin | September 22, 2020 Microbix Presenting COVID-19 Product Results To Industry

Microbix Announces Extension Of Warrant Expiry Dates

By Microbix Admin | September 17, 2020 Microbix Announces Quality Products Distribution Agreement

Microbix Announces Board Changes

By Microbix Admin | September 15, 2020 Microbix Announces Board Changes

Microbix’s REDx™ Controls Attain Australian TGA Registration

By Microbix Admin | September 10, 2020 Microbix’s REDx™ Controls Attain Australian TGA Registration

Q3 Fiscal 2020

By Microbix Admin | August 14, 2020 Microbix Announces $6.0 Million of Financings

Curious To See How We Perform A COVID Test?

By Microbix Admin | July 21, 2020 Microbix

Microbix Shares Become Available For U.S. Investors

By Microbix Admin | July 14, 2020 Microbix Shares Become Available For U.S. Investors

Microbix COVID-19 QAPs Attain EU “CE Mark” Registration

By Microbix Admin | June 5, 2020 Microbix COVID-19 QAPs Attain EU “CE Mark” Registration

Microbix Announces Quality Products Distribution Agreement

By Microbix Admin | June 4, 2020 Microbix Announces Quality Products Distribution Agreement

Microbix Engaged To Develop & Supply Custom QAPs™

By Microbix Admin | June 2, 2020 Microbix Engaged To Develop & Supply Custom QAPs™

Microbix Expanding QAPs™ Production Capacity

By Microbix Admin | May 27, 2020 Microbix Expanding QAPs™ Production Capacity

Microbix Achieves Full Utilization Of Its Bioreactors

By Microbix Admin | May 19, 2020 Microbix Achieves Full Utilization Of Its Bioreactors

Microbix Announces Quality Products Distribution Agreement

By Microbix Admin | May 15, 2020 Microbix Announces Quality Products Distribution Agreement

Microbix Reports Record Second Quarter Sales

By Microbix Admin | May 14, 2020

Microbix Reports Results For Q2 Fiscal 2020

By Microbix Admin | May 14, 2020 Microbix Shares Become Available For U.S. Investors

Microbix Announces Quality Products Distribution Agreement

By Microbix Admin | May 12, 2020 Microbix Announces Quality Products Distribution Agreement

Microbix COVID-19 QAPs Now Available for U.S. Labs

By Microbix Admin | May 7, 2020

Microbix COVID-19 QAPs™ Now Available For U.S. Labs

By Microbix Admin | May 7, 2020 Microbix COVID-19 QAPs™ Now Available For U.S. Labs

Microbix Begins Providing COVID-19 Test Quality Products

By Microbix Admin | May 6, 2020 Microbix Begins Providing COVID-19 Test Quality Products

Microbix Announces Quality Products Distribution Agreement

By Microbix Admin | April 27, 2020 Microbix Announces Quality Products Distribution Agreement

Microbix Participating In COVID-19 Virtual Conference

By Microbix Admin | April 21, 2020 Microbix Participating In COVID-19 Virtual Conference

Microbix Attains Health Canada Establishment Licensing

By Microbix Admin | April 21, 2020 Microbix Attains Health Canada Establishment Licensing

How Microbix Core Competency Leads To COVID-19 Products

By Microbix Admin | April 14, 2020 Microbix

Microbix & Oneworld Create COVID-19 Test Quality Program

By Microbix Admin | April 9, 2020 Microbix Attains Health Canada Establishment Licensing

Microbix Announces Annual And Special Meeting Voting Results

By Microbix Admin | April 1, 2020

Microbix Creates Quality Assessment Product For COVID-19 Tests

By Microbix Admin | March 30, 2020

Microbix Annual General Meeting Process Update

By Microbix Admin | March 25, 2020

Microbix Announces Quality Products Distribution Agreement

By Microbix Admin | March 24, 2020

Microbix Announces Issuance Of Stock Options

By Microbix Admin | February 25, 2020 Microbix Announces Addition to Board of Directors

Microbix Reports Results For Q1 Fiscal 2020

By Microbix Admin | February 13, 2020

Microbix Completes Non-Brokered Private Placement Of $2.3 Million

By Microbix Admin | January 31, 2020

Microbix Reports Results For Fiscal 2019

By Microbix Admin | December 20, 2019 Microbix Shares Become Available For U.S. Investors

Microbix Invited To Present Product Results At HPV Congress

By Microbix Admin | December 2, 2019

Microbix Wins Ontario Business Award

By Microbix Admin | November 18, 2019 Microbix Announces Addition to Board of Directors

Microbix Presenting Product Results At Industry Conference

By Microbix Admin | October 8, 2019

Microbix Presenting At StableView TECH19 Conference

By Microbix Admin | October 1, 2019 Microbix Announces Addition to Board of Directors

Microbix Presenting At Muskoka Capital Conference

By Microbix Admin | September 25, 2019

Microbix Quality Products Enter U.S. Market

By Microbix Admin | September 19, 2019 Microbix COVID-19 QAPs™ Now Available For U.S. Labs

Microbix Quality Products Attain European Registration

By Microbix Admin | September 5, 2019

Microbix Reports Results For Q3 Fiscal 2019

By Microbix Admin | August 12, 2019 Microbix Shares Become Available For U.S. Investors

Microbix Provides Bioreactor Update

By Microbix Admin | August 1, 2019

FedDev Ontario Supports New Microbix Facility In Mississauga

By Microbix Admin | July 30, 2019 Microbix Announces Quality Products Distribution Agreement

Microbix Reports Results For Q2 Fiscal 2019

By Microbix Admin | May 13, 2019

Microbix To Present At Bloom Burton Conference

By Microbix Admin | April 29, 2019 Microbix Shares Become Available For U.S. Investors

Microbix Announces Management Changes

By Microbix Admin | April 18, 2019 Microbix Announces Quality Products Distribution Agreement

Microbix Announces Annual Meeting Voting Results

By Microbix Admin | March 28, 2019

Microbix Announces Issuance Of Stock Options

By Microbix Admin | February 25, 2019 Microbix Announces Addition to Board of Directors

Microbix Reports Results For Q1 Fiscal 2019

By Microbix Admin | February 12, 2019 Microbix Shares Become Available For U.S. Investors

Microbix Provides Quality Assessment Products Update

By Microbix Admin | February 5, 2019

Microbix Enhances Quality Management System

By Microbix Admin | December 24, 2018

Microbix Reports Results For Fiscal 2018

By Microbix Admin | December 21, 2018

Microbix Wins Business Award Of Excellence

By Microbix Admin | November 19, 2018

Microbix Exhibiting At MEDICA Trade Fair

By Microbix Admin | November 6, 2018

Microbix To Present At Muskoka Capital Conference

By Microbix Admin | September 27, 2018

Microbix Reports Record Third Quarter Sales

By Microbix Admin | August 14, 2018

Microbix Exhibiting At AACC Exposition

By Microbix Admin | July 26, 2018

Microbix To Present At Okanagan Capital Conference

By Microbix Admin | July 12, 2018 Microbix to Present at Bloom Burton Investor Conference

Microbix Reports Record Second Quarter Sales

By Microbix Admin | May 14, 2018

Microbix Completes Multiple Facility Upgrades

By Microbix Admin | May 8, 2018 Microbix Expanding QAPs™ Production Capacity

Microbix To Present At Bloom Burton Conference

By Microbix Admin | April 30, 2018 Microbix Participating In COVID-19 Virtual Conference

Microbix Engages Drug Licensing Advisor

By Microbix Admin | April 26, 2018

Microbix Announces Annual And Special Meeting Voting Results

By Microbix Admin | April 3, 2018

Microbix Reports Record First Quarter Sales – Year-Over-Year Sales Growth Of 48%

By Microbix Admin | February 14, 2018

Microbix Featured At Cantech Investment Conference

By Microbix Admin | January 29, 2018

Microbix Expands Quality Assessment Product Family

By Microbix Admin | January 18, 2018

Microbix Reports Full Year And Fourth Quarter Results – Record Sales Of $10.2 Million Achieved For Fiscal 2017

By Microbix Admin | December 21, 2017

Microbix Confirms Ramp-Up Of Production – Bioreactor Capacity Increasing By 500%

By Microbix Admin | November 27, 2017

Microbix Completes Second Tranche Of Brokered Private Placement Tranche Gross Proceeds Of $1,164,640, Total Proceeds Of $3,500,000

By Microbix Admin | October 27, 2017

Microbix Completes Brokered Private Placement – Gross Proceeds Of $2.3 Million

By Microbix Admin | October 19, 2017

Microbix Announces End Of Legal Dispute – Allegations By ZeptoMetrix Withdrawn

By Microbix Admin | October 11, 2017

Microbix Announces First Shipment Of Bioreactor Antigen

By Microbix Admin | September 13, 2017

Microbix To Amend Share Purchase Warrant Terms

By Microbix Admin | August 24, 2017 Record Q2 Sales of $4.35 million, Record Net Earnings of $0.8 million

Microbix Reports Record Third Quarter & Nine Month Sales – Year-Over-Year Sales Growth Exceeding 20%

By Microbix Admin | August 14, 2017